Bicycle Therapeutics (BCYC) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bicycle Therapeutics

    NASDAQ: BCYC · Real-Time Price · USD
    7.40
    -0.14 (-1.86%)
    At close: Sep 26, 2025, 3:59 PM
    7.54
    1.89%
    After-hours: Sep 26, 2025, 05:16 PM EDT

    Bicycle Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.82 -3.56 -7.79 -22.83
    PEG Ratio
    		 0.11 -0.11 -0.18 -60.73
    PS Ratio
    		 23.10 23.85 60.70 130.42
    PB Ratio
    		 1.03 1.73 3.24 4.41
    P/FCF Ratio
    		 -4.91 -10.12 -8.35 -90.67
    P/OCF Ratio
    		 -4.95 -10.61 -10.2 -103.12
    OCF/S Ratio
    		 -4.67 -2.25 -5.95 -1.26
    Debt / Equity Ratio
    		 0.01 0.12 0.16 0.13
    Quick Ratio
    		 13.81 8.08 6.92 12.65
    Current Ratio
    		 13.81 8.08 6.92 12.65
    Asset Turnover
    		 0.04 0.05 0.04 0.02
    Interest Coverage
    		 -121.31 -58.21 -34.88 -21.99
    Return on Equity
    		 -0.21 -0.49 -0.42 -0.19
    Return on Assets
    		 -0.18 -0.3 -0.27 -0.14
    Return on Invested Capital
    		 -0.23 -0.36 -0.32 -0.14
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 -3.9 -4.8 -4.64 -2.84
    Net Profit Margin
    		 -4.79 -6.7 -7.79 -5.71
    Pretax Profit Margin
    		 -4.93 -6.64 -7.9 -5.85
    Operating Profit Margin
    		 -5.95 -7.04 -8.07 -5.61
    FCF Margin
    		 -4.7 -2.36 -7.27 -1.44
    EBITDA Margin
    		 -4.67 -6.8 -7.81 -5.48

    Add to Watchlist